V116517
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for V116517, covering 2013-12-05 to 2014-05-12. Get the full timeline:
Most recent: Clinical Trial Update: Analgesic Efficacy and Safety of V116517 in Subjects With Moderate to Severe Chronic Pain Due to Postherpetic Neuralgia (PHN) [Phase 2]